CC BY 4.0 · Endoscopy
DOI: 10.1055/a-2538-9316
Original article

Outcomes after radical endoscopic resection of high-risk T1 esophageal adenocarcinoma: an international multicenter retrospective cohort study

Man Wai Chan
1   Gastroenterology and Hepatology, Amsterdam University Medical Centres, Amsterdam, Netherlands (Ringgold ID: RIN522567)
2   Gastroenterology and Hepatology, Cancer Centre Amsterdam, Amsterdam, Netherlands (Ringgold ID: RIN571143)
3   Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, Netherlands (Ringgold ID: RIN571165)
,
Rehan Haidry
4   Digestive Diseases & Surgery Institute, Cleveland Clinic London, London, United Kingdom of Great Britain and Northern Ireland (Ringgold ID: RIN591481)
5   Division of Gastroenterology and Hepatology, University College London, London, United Kingdom of Great Britain and Northern Ireland (Ringgold ID: RIN4919)
,
6   Medicine, University College London, London, United Kingdom of Great Britain and Northern Ireland (Ringgold ID: RIN4919)
7   Department of Gastroenterology, Cleveland Clinic London, London, United Kingdom of Great Britain and Northern Ireland (Ringgold ID: RIN591481)
,
Massimiliano di Pietro
8   Early Cancer Institute, University of Cambridge, Cambridge, United Kingdom of Great Britain and Northern Ireland (Ringgold ID: RIN2152)
9   Digestive Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom of Great Britain and Northern Ireland (Ringgold ID: RIN2153)
,
Andreas V. Hadjinicolaou
10   Division of Gastroenterology and Hepatology, Department of Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom of Great Britain and Northern Ireland (Ringgold ID: RIN2153)
11   Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, United Kingdom of Great Britain and Northern Ireland (Ringgold ID: RIN2152)
,
Maximilien Barret
12   Gastroenterology, Cochin Hospital, Paris, France
,
13   Gastroenterology, Hôpital Cochin, Paris, France (Ringgold ID: RIN26935)
,
Stefan Seewald
14   Center for Gastroenterology, Hirlanden Clinic Zurich, Zurich, Switzerland
,
15   Department of Gastroenterology and Hepatology, University Hospital Leuven, Leuven, Belgium
,
Philippe Nafteux
16   Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium (Ringgold ID: RIN60182)
,
Michael J. Bourke
17   Gastroenterology, Westmead Hospital, Sydney, Australia
,
18   Gastroenterology and Hepatology, Westmead Hospital, Westmead, Australia (Ringgold ID: RIN8539)
19   Medicine, The University of Sydney Westmead Clinical School, Westmead, Australia (Ringgold ID: RIN216997)
,
Pradeep Mundre
20   Gastroenterology, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, United Kingdom of Great Britain and Northern Ireland (Ringgold ID: RIN1906)
,
Arnaud Lemmers
21   Gastroenterology, Hepatopancreatology and Digestive Oncology, Hopital Erasme, Bruxelles, Belgium (Ringgold ID: RIN70496)
,
Clémence Vuckovic
21   Gastroenterology, Hepatopancreatology and Digestive Oncology, Hopital Erasme, Bruxelles, Belgium (Ringgold ID: RIN70496)
,
Oliver Pech
22   Gastroenterology, Regensburg Hospital of the Hospitaller Order of the Brothers of Saint John of God, Regensburg, Germany (Ringgold ID: RIN155897)
,
Philippe Leclercq
23   Department of Gastroenterology, Clinique CHC MontLégia, Liège, Belgium
,
Emmanuel Coron
24   Gastroenterology Unit, University of Geneva, Nantes, France (Ringgold ID: RIN27212)
,
25   Pathology, Amsterdam UMC Locatie AMC, Amsterdam, Netherlands (Ringgold ID: RIN26066)
26   pathology, Amsterdam UMC Locatie AMC, Amsterdam, Netherlands (Ringgold ID: RIN26066)
,
27   Gastroenterology and hepatology, Amsterdam UMC Locatie De Boelelaan, Amsterdam, Netherlands (Ringgold ID: RIN1209)
,
Roos E. Pouw
28   Gastroenterology and Hepatology, Amsterdam UMC Locatie AMC, Amsterdam, Netherlands (Ringgold ID: RIN26066)
› Author Affiliations

Introduction Post-endoscopic resection (ER) management of high-risk T1 esophageal adenocarcinoma (EAC) is debated, with conflicting reports on lymph node metastases (LNM) We aimed to assess outcomes following radical ER for high-risk T1 EAC. Methods We identified patients who underwent radical ER (tumor-negative deep margin) of high-risk T1 EAC, followed by surgery or endoscopic surveillance, between 2008-2019 across 11 international centers. Results In total, 106 patients (86 men, 70 ±11 years) were included. Of these, 26 patients (64 ±11 yrs) underwent additional surgery, with residual T1 EAC in 5 (19%) and LNM in 2 (8%) cases. After median 47 (IQR 32-79) months follow-up, 2/26 (8%) developed LNM/distant metastasis (DM), with 1 (4%) EAC-related death. There was 1/26 (4%) unrelated death and 4/26 (15%) were lost to follow-up. Eighty patients (71 ±9 yrs) entered endoscopic surveillance. Over 46 (IQR 25-59) months follow-up, 5/80 (6%) developed LNM/DM, with 4/80 (5%) EAC-related deaths. There were 15/80 (19%) unrelated deaths, and 10/80 (13%) were lost to follow-up. Overall rates during follow-up were 6% (95% CI 2-12) for LNM, 7% (95% CI 3-13) for LNM/DM, 5% (95% CI 2-11) for EAC-related mortality, and 20% (95% CI 13-29) for overall mortality. Conclusion Our findings present low rates of LNM after radical ER of high-risk T1 EAC, consistent with other endoscopy-focused studies. Post-surgical patients are still at risk for metastasis and disease-specific mortality. These results suggest that endoscopic surveillance is suitable for selected cases, but further prospective studies are needed to refine patient selection and confirm optimal outcomes.



Publication History

Received: 11 May 2024

Accepted after revision: 12 February 2025

Accepted Manuscript online:
13 February 2025

© . The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany